LSE:HIK (Hikma Pharmaceuticals Plc)

Hikma Pharmaceuticals Plc (LSE: HIK)
Latest News

Investing Articles

A dividend stock and a growth stock I’d buy in February

Edward Sheldon identifies a dividend powerhouse and a growth stock that offer value at present.

Read more »

Investing Articles

Kick-start 2017 with these explosive growth stocks

Bilaal Mohamed thinks these two pharmacetutical firms could be on the verge of spectacular gains in 2017.

Read more »

Investing Articles

2 top healthcare shares for growth investors right now

Are these the best healthcare stocks to buy for 2017?

Read more »

Investing Articles

2 defensive stocks looking attractive since recent falls

These defensive dividend growers are on sale.

Read more »

Investing Articles

Could Vectura Group plc grow to be a FTSE 100 company within 10 years?

Vectura Group plc (LON:VEC) could follow in the footsteps of Hikma Pharmaceuticals (LON:HIK), says G A Chester.

Read more »

Investing Articles

Which of these Footsie healthcare stars should you buy after today’s news?

Royston Wild discusses the investment prospects of two Footsie medical giants.

Read more »

Investing Articles

Why did shares in Hikma Pharmaceuticals plc and GlaxoSmithKline plc crash last week?

Shares in GlaxoSmithKline plc (LON: GSK) and Hikma Pharmaceuticals plc (LON: HIK) are crashing but should you sell?

Read more »

Investing Articles

Should you ditch these Footsie pharma stocks right now!

Are these blue chips now too dicey to hold?

Read more »

Investing Articles

2 firms to retire on

Here’s an elegant strategy for a financially worry-free retirement.

Read more »

Investing Articles

Top stocks for November

We asked our analysts to share their top stock picks for the coming month.

Read more »

Investing Articles

Directors are buying these high growth stocks – should you follow them?

Edward Sheldon looks at two stocks that have seen sizeable director's purchases in September.

Read more »

Investing Articles

Are these the FTSE 100’s best contrarian bets?

Royston Wild reveals two FTSE 100 (INDEXFTSE: UKX) giants well overdue for a share price upturn.

Read more »